0001415889-24-006005.txt : 20240229 0001415889-24-006005.hdr.sgml : 20240229 20240229211517 ACCESSION NUMBER: 0001415889-24-006005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240227 FILED AS OF DATE: 20240229 DATE AS OF CHANGE: 20240229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RABINOWITZ DANIEL CENTRAL INDEX KEY: 0001857843 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 24706564 MAIL ADDRESS: STREET 1: C/O NATERA, INC. STREET 2: 13011 MCCALLEN PASS BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 4 1 form4-02292024_090201.xml X0508 4 2024-02-27 0001604821 Natera, Inc. NTRA 0001857843 RABINOWITZ DANIEL C/O NATERA, INC. 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 false true false false SEC. AND CHIEF LEGAL OFFICER 1 Common Stock 2024-02-27 4 M 0 27500 10.41 A 231718 D Common Stock 2024-02-27 4 M 0 7807 9.29 A 239525 D Common Stock 2024-02-27 4 S 0 35307 75.0927 D 204218 D Common Stock 2024-02-29 4 M 0 20526 9.29 A 224744 D Common Stock 2024-02-29 4 S 0 100 85.10 D 224644 D Common Stock 2024-02-29 4 S 0 2600 86.6708 D 222044 D Common Stock 2024-02-29 4 S 0 3400 87.8721 D 218644 D Common Stock 2024-02-29 4 S 0 14426 89.7235 D 204218 D Stock Option (right to buy) 10.41 2024-02-27 4 M 0 27500 0 D 2027-06-08 Common Stock 27500 0 D Stock Option (right to buy) 9.29 2024-02-27 4 M 0 7807 0 D 2028-03-08 Common Stock 7807 20526 D Stock Option (right to buy) 9.29 2024-02-29 4 M 0 20526 0 D 2028-03-08 Common Stock 20526 0 D The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.43 to $87.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.80 to $88.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.53 to $89.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option shares are fully exercisable. /s/ Tami Chen, Attorney-in-Fact 2024-02-29